With the analysis among 1,637 patents, we discovered top 300 key players by total patent application. Novartis AG, Toray Industries, Inc., Immatics Biotechnologies GmbH are dominant in this area. They take 23.52% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 198
Tokyo-to, Japan
Patent: 109
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 78
Eureka Therapeutics, Inc.
California, United States
Patent: 66
New Jersey, United States
Patent: 41
Bayern, Germany
Patent: 32
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 30
ZURICH, Switzerland
Patent: 29
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 24
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 24
With the analysis among 105 patents, we discovered top 21 start-ups by total patent application. DRAGONFLY Therapeutics, Inc., Nanjing Bioheng Biotech Co., Ltd., Dren Bio, Inc. are active in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 30
Nanjing Bioheng Biotech Co., Ltd.
Jiangsu Sheng, China
Patent: 12
California, United States
Patent: 9
Institut National de la Santé et de la Recherche Médicale
Nanjing IASO Biotherapeutics Co., Ltd.
Jiangsu Sheng, China
Patent: 7
Shanghai Shi, China
Patent: 6
Missouri, United States
Patent: 5
Gyeonggi-do, South Korea
Patent: 5
Texas, United States
Patent: 5
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 4
With the analysis among related 1,006 patents applied in the last 5 years. We discover 320 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, Novartis AG, DRAGONFLY Therapeutics, Inc. take 9.64% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 34
Basel-Stadt, Switzerland
Patent: 33
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 30
ZURICH, Switzerland
Patent: 29
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 24
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 24
Shanghai ChemExplorer Co., Ltd
Shanghai Shi, China
Patent: 21
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 19
California, United States
Patent: 18
Bayern, Germany
Patent: 17
With the analysis among related 1,006 patents in last 5 years, we discover 252 new entrants. DRAGONFLY Therapeutics, Inc., Numab Therapeutics AG, Shanghai Hengrui Pharmaceutical Co., Ltd. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 30
ZURICH, Switzerland
Patent: 29
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 24
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 24
Shanghai ChemExplorer Co., Ltd
Shanghai Shi, China
Patent: 21
California, United States
Patent: 18
Shenzhen People's Hospital
Guangdong Sheng, China
Patent: 16
Nanjing Bioheng Biotech Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Massachusetts, United States
Patent: 10
With the analysis among 549 patents, we discovered top 90 universities and scientific research institutions by total patent application. The Scripps Research Institute, Massachusetts Institute of Technology, The University of North Carolina at Chapel Hill are dominant in this area. They take 32.79% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 42
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 20
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 16
University of Southern California
California, United States
Patent: 13
California Institute of Technology
California, United States
Patent: 12
Shanghai Shi, China
Patent: 12
New York, United States
Patent: 10
The Johns Hopkins University
The Rockefeller University
New York, United States
Patent: 8
Universidad Autónoma de Nuevo León
Nuevo León, Mexico
Patent: 8